These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


243 related items for PubMed ID: 15028804

  • 1. A new era for transjugular intrahepatic portosystemic shunts?
    Saxon RR.
    J Vasc Interv Radiol; 2004 Mar; 15(3):217-9. PubMed ID: 15028804
    [No Abstract] [Full Text] [Related]

  • 2. Transjugular intrahepatic portosystemic shunt creation with the Viatorr expanded polytetrafluoroethylene-covered stent-graft.
    Hausegger KA, Karnel F, Georgieva B, Tauss J, Portugaller H, Deutschmann H, Berghold A.
    J Vasc Interv Radiol; 2004 Mar; 15(3):239-48. PubMed ID: 15028808
    [Abstract] [Full Text] [Related]

  • 3. Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications.
    Siramolpiwat S.
    World J Gastroenterol; 2014 Dec 07; 20(45):16996-7010. PubMed ID: 25493012
    [Abstract] [Full Text] [Related]

  • 4. Long-term clinical outcome and survival predictors in patients with cirrhosis after 10-mm-covered transjugular intrahepatic portosystemic shunt.
    Tejedor-Tejada J, Fuentes-Valenzuela E, García-Pajares F, Nájera-Muñoz R, Almohalla-Álvarez C, Sánchez-Martín F, Calero-Aguilar H, Villacastín-Ruiz E, Pintado-Garrido R, Sánchez-Antolín G.
    Gastroenterol Hepatol; 2021 Nov 07; 44(9):620-627. PubMed ID: 33249114
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study.
    Bureau C, Garcia Pagan JC, Layrargues GP, Metivier S, Bellot P, Perreault P, Otal P, Abraldes JG, Peron JM, Rousseau H, Bosch J, Vinel JP.
    Liver Int; 2007 Aug 07; 27(6):742-7. PubMed ID: 17617116
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Portosystemic shunts versus endoscopic therapy for esophageal varices after the first bleeding: does the Cochrane analysis give a complete answer?].
    Grønbaek H, Thomsen KL, Ott P, Vilstrup H.
    Ugeskr Laeger; 2007 Aug 20; 169(34):2761-3. PubMed ID: 17878011
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of complications of portal hypertension in patients with liver cirrhosis].
    Grønbaek H, Astrup LB, Nielsen DT, Vilstrup H.
    Ugeskr Laeger; 2003 Jan 27; 165(5):439-42. PubMed ID: 12599838
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Bleeding ectopic varices in cirrhosis: the role of transjugular intrahepatic portosystemic stent shunts.
    Kochar N, Tripathi D, McAvoy NC, Ireland H, Redhead DN, Hayes PC.
    Aliment Pharmacol Ther; 2008 Aug 01; 28(3):294-303. PubMed ID: 19086235
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Transjugular intrahepatic portosystemic shunt for the prevention of recurrent esophageal variceal bleeding in patients with cavernous transformation of portal vein.
    Li ZP, Wang SS, Wang GC, Huang GJ, Cao JQ, Zhang CQ.
    Hepatobiliary Pancreat Dis Int; 2018 Dec 01; 17(6):517-523. PubMed ID: 30262421
    [Abstract] [Full Text] [Related]

  • 18. Biliary Obstruction following Transjugular Intrahepatic Portosystemic Shunt Creation in Patients with Variceal Bleeding.
    Meng J, Yang S, Ding W, He C, Wu X.
    J Vasc Interv Radiol; 2016 Apr 01; 27(4):558-61. PubMed ID: 27013003
    [Abstract] [Full Text] [Related]

  • 19. Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stents versus bare stents: a meta-analysis.
    Yang Z, Han G, Wu Q, Ye X, Jin Z, Yin Z, Qi X, Bai M, Wu K, Fan D.
    J Gastroenterol Hepatol; 2010 Nov 01; 25(11):1718-25. PubMed ID: 21039832
    [Abstract] [Full Text] [Related]

  • 20. Improved clinical outcome with transjugular intrahepatic portosystemic stent-shunt utilizing polytetrafluoroethylene-covered stents.
    Tripathi D, Ferguson J, Barkell H, Macbeth K, Ireland H, Redhead DN, Hayes PC.
    Eur J Gastroenterol Hepatol; 2006 Mar 01; 18(3):225-32. PubMed ID: 16462534
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.